Clinical Trial Update: A Safety and PK Study of EC-18 in Healthy Subjects [Phase 1]

View source ↗

Summary

This Phase 1 study reports safety and pharmacokinetic data for EC-18 in healthy subjects, evaluating tolerability and PK parameters in a first-in-human trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia

Drugs mentioned

• EC-18

Snippet

Sponsor: Enzychem Lifesciences Corporation | Conditions: Chemotherapy-induced Neutropenia | Phase 1 | Status: COMPLETED